What’s Driving Growth in the RNA Sequencing Services Market? Insights into Key Trends and Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the rna sequencing services market right now?
The RNA sequencing services market has grown significantly, set to increase from $3.58 billion in 2024 to $4 billion in 2025, at a CAGR of 11.6%. Historical growth factors include rising demand for personalized medicine, advancements in bioinformatics, emphasis on drug discovery, adoption in agricultural research, and expanded applications in clinical diagnostics.
How fast Is the rna sequencing services market expected to grow, and what’s its future value?
The RNA sequencing services market is expected to expand significantly, reaching $6.13 billion in 2029 at a CAGR of 11.3%. Growth is driven by single-cell RNA sequencing advancements, AI and ML-based data analysis, non-coding RNA biomarker research, demand for transcriptomic analysis in immunotherapy, and academia-industry collaborations. Key trends include long-read sequencing adoption, cloud-based analysis, RNA splicing analysis demand, and multi-omics data integration.
Get your rna sequencing services market report here!
https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report
What are the leading drivers of growth in the rna sequencing services market?
The surge in necessity for personalized medicine is playing a pivotal role in driving the expansion of the RNA sequencing services market. Personalized medicine implies the adaptation of healthcare treatment to unique individual traits like genetics or lifestyle, with a view to amplify effectiveness and minimize detrimental effects. The escalating need for personalized medicine is stimulated by its inherent capability to proffer more efficient treatments, advancements in the sector of genomics, heightened complexity of diseases, and regulatory backing. RNA sequencing services facilitate the classification of various disease subtypes, discovering biomarkers, the determination of therapeutic targets, predictions of treatment responses and the surveillance of disease progression and treatment outcomes. Personalized medicine methodologies utilize RNA sequencing technologies to deliver customized and efficient medications that target the distinctive molecular characteristics of individual patients. As an illustration, the Personalized Medicine Coalition, a non-profit organization based in the US, reported that in February 2024, the FDA (Food and Drug Administration) sanctioned 16 unique personalized therapies for patients diagnosed with rare diseases in 2023, a significant increase compared to six in 2022. The approved personalized therapies in 2023 also included seven drugs for cancer and three for other diseases and conditions. Consequently, the intensifying demand for personalized medicine is catalyzing the expansion of the RNA sequencing services market in the forthcoming period.
What are the key segments defining the rna sequencing services market?
The RNA sequencing services market covered in this report is segmented –
1) By Type: Ribosomal RNA (rRNA), Transfer RNA (tRNA), Long non-coding RNA (lncRNA)
2) By Sequencing Method: Next Generation Sequencing Methods, Other Sequencing Methods
3) By Application Area: Research Purposes, Diagnostic Purposes
4) By End Users: Academic And Government Institutes And Research Centers, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users
Subsegments:
1) By Ribosomal RNA (rRNA): Total RRNA Sequencing, RRNA Depletion
2) By Transfer RNA (tRNA): TRNA Profiling, TRNA Sequencing
3) By Long Non-Coding RNA (lncRNA): lncRNA Profiling, lncRNA Sequencing
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14991&type=smp
Who are the key players steering the development of the rna sequencing services market?
Major companies operating in the RNA sequencing services market are Thermo Fisher Scientific Inc., Feng Chi Biotech Corp., Illumina Inc., Qiagen NV, BGI Genomics Co. Ltd., Azenta Inc., Abcam Limited, Novogene Co. Ltd., Genewiz Inc., Diagenode LLC, CD Genomics, CeGaT GmbH, Lexogen GmbH, BaseClear BV, Active Motif Inc., Microsynth AG, RayBiotech Inc., Genomax Technologies Pte. Ltd., Phalanx Biotech Group Inc., Creative Biogene, SeqMatic LLC, Genohub Inc., Otogenetics, LC Sciences, Admera Health, Arraystar Inc., IGA Technology, Yaazh Xenomics
What emerging trends are influencing the growth of the rna sequencing services market?
Key players in the RNA sequencing services market are prioritizing automation to minimize the risk of human error, exemplified through next-generation sequencing (NGS) assay, with the goal of improving both efficiency and precision in generating and analyzing data. RNA next-generation sequencing (RNA-seq) assays are valuable tools in the domains of molecular biology and genomics, enabling the exploring of a biological sample’s transcriptome. For instance, in June 2023, the U.S-based precision medicine technology firm, Tempus, introduced its independent RNA next-generation sequencing assay, Tempus xR. This trailblazing assay, developed for solid tumors, provides an in-depth analysis of the entire transcriptome and draws attention to clinically relevant fusions in over 100 targeted genes, along with altered splicing for MET Exon 14 and EGFRvIII. Understanding the importance of RNA sequencing data, Tempus has historically merged both RNA and DNA sequencing in its standard xT broad-panel assay. Presently, clients can choose to order each test independently or together, and have the option to enhance xR with certain Tempus algorithmic tests. This service accommodates physicians interested in RNA fusions or altered splicing, as well as service providers, investigators, and biopharmaceutical firms aiming for comprehensive RNA sequencing analysis of their existing samples.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14991
Which regions are most influential in expanding the rna sequencing services market?
North America was the largest region in the RNA sequencing services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the RNA sequencing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Clinical Oncology Next Generation Sequencing Global Market Report 2024
RNA Targeting Small Molecule Drug Discovery Global Market Report 2024
Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
